Showing results (761-770 of 2,903) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|October 31, 2019
Mechanism and therapeutic prospect of resveratrol combined with TRAIL in the treatment of renal cell carcinomaYan Zeng, Feng-di Li, Chun-Wei Shi, et al.Cancer Gene Therapy|December 9, 2022
Pals1 functions in redundancy with SMAP1 to inhibit Arf6 in order to prevent Rac1-dependent colorectal cancer cell migration and invasionJulia Harms, Simona Mareike Lüttgenau, Christin Emming, et al.Cancer Gene Therapy|November 21, 2022
A20 interacts with mTORC2 to inhibit the mTORC2/Akt/Rac1 signaling axis in hepatocellular carcinoma cellsXinyu Wang, Ying Xiao, Yanlei Dong, et al.Cancer Gene Therapy|April 2, 2020
In vivo antitumor activity by dual stromal and tumor-targeted oncolytic measles virusesYuqi Jing, Valery Chavez, Natasha Khatwani, et al.Cancer Gene Therapy|October 3, 2020
The changing face of gastric cancer: epidemiologic trends and advances in novel therapiesRaghav Chandra, Neeraja Balachandar, Sam Wang, et al.Cancer Gene Therapy|June 11, 2021
Non-homologous dsODN increases the mutagenic effects of CRISPR-Cas9 to disrupt oncogene E7 in HPV positive cellsWeiwen Fan, Miao Yu, Xin Wang, et al.Cancer Gene Therapy|July 29, 2021
Downregulation of TMEM220 promotes tumor progression in Hepatocellular CarcinomaTing Li, Lei Guan, Guangbo Tang, et al.Cancer Gene Therapy|December 14, 2020
TAF1A and ZBTB41 serve as novel key genes in cervical cancer identified by integrated approachesMingyuan Wang, Jingnan Liao, Jinjin Wang, et al.Cancer Gene Therapy|January 5, 2021
Genomic alterations caused by HPV integration in a cohort of Chinese endocervical adenocarcinomasWenhui Li, Wanjun Lei, Xiaopei Chao, et al.Cancer Gene Therapy|January 5, 2021
PDLIM2 prevents the malignant phenotype of hepatocellular carcinoma cells by negatively regulating β-cateninXiaoming Jiang, Zhe Chu, Yang Cao, et al.Pageof 291